期刊
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
卷 18, 期 4, 页码 331-346出版社
TAYLOR & FRANCIS AS
DOI: 10.1080/14737159.2018.1453358
关键词
Male infertility; genetics; genes; spermatogenesis; Y chromosome; azoospermia; oligozooseprmia; exome
类别
资金
- Spanish Ministry of Health-Instituto Carlos III [FIS/FEDER PI14/01250, PI17/01822]
- European Commission - Reproductive Biology Early Research Training (REPROTRAIN) [289880]
Introduction: Male infertility affects about 7% of the general male population, and it is a multifactorial, polygenic pathological condition. Known genetic factors, accounting for about 20-25% of male factor infertility, are present in each etiological category: i) hypothalamic-pituitary axis dysfunction; ii) quantitative and qualitative alterations of spermatogenesis; iii) ductal obstruction/dysfunction.Areas covered: All routinely available genetic tests are described. Indication for testing for chromosomal anomalies and Y chromosome microdeletions is based on sperm count (severe oligozoospermia/azoospermia). Mutation screening in candidate genes is indicated in specific semen/testis phenotypes. In about 40% of infertile patients, the aetiology remains unknown (idiopathic cases') and whole exome sequencing may reveal novel genetic causes.Expert commentary: Genetic testing is essential for its relevance in clinical decision-making. For instance, it helps to avoid unnecessary surgical or medical treatments and it may provide prediction for testicular sperm retrieval. The highest frequency of genetic anomalies is observed in severe spermatogenic impairment, which can be treated with in vitro fertilization (IVF). Given the risk of transmitting genetic disorders to the future offspring through IVF, the diagnosis of known and the discovery of novel genetic factors in idiopathic infertility is of outmost clinical importance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据